Pharmaceutical

FDA approves AbbVie’s Emblaveo for intra-abdominal infections

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

Feb 11, 2025 - 06:00
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.
Read the original article

Tags:

Previous Article

Eton secures US patent for diabetes insipidus treatment

Next Article

Insilico Medicine Unveils Key Developmental Milestones and Timelines for Novel A...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sterilisation Solutions, Equipment and Services for the Pharmaceutical Industry

Sterilisation Solutions, Equipment and Services for the...

Oct 2, 2024

Opinion: Do chatbots have more time to be empathetic than physicians?

Opinion: Do chatbots have more time to be empathetic th...

May 17, 2023

Immune Thrombocytopenia by NovelMed Therapeutics for Id...

Jul 1, 2023